Aim: To report on the MRI compatibility of the Ex-PRESS glaucoma filtration device, a tiny metallic implant placed into the anterior chamber of the eye that is much smaller than traditional glaucoma shunts, and to educate the radiology community regarding its appearance.
Materials And Methods: Seven patients with Ex-PRESS glaucoma filtration devices were identified that had undergone MRI at San Francisco General Hospital/University of California San Francisco Medical Center by searching and cross-referencing the radiology reporting system and the electronic medical record. MRI images were reviewed for artefact interfering with interpretation. Ophthalmology examinations were reviewed for evidence of complications.
Results: Eighteen individual MRI examinations were performed during 12 unique MRI events on these 7 patients. 13/18 individual MRI examinations and 7/12 MRI events were performed at 3 T with the others performed at 1.5 T. Mean time from Ex-PRESS implantation to MRI was 17.5 months. Mean time from MRI to first ophthalmology examination was 1.1 months and from MRI to latest ophthalmology examination was 6.6 months. Susceptibility artefact did not interfere with image interpretation and no complications related to MRI were encountered.
Conclusion: The Ex-PRESS glaucoma filtration device appears to be safe for MRI at 1.5 and 3 T and does not produce significant susceptibility artefact to affect diagnostic interpretation adversely.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385419 | PMC |
| http://dx.doi.org/10.1016/j.crad.2015.01.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Compared to Trabeculectomy, Ex-Press Surgery Significantly Decreased the Loss of Corneal Endothelial Cell Density in Low-Intraocular-Pressure Glaucoma: 3-Year Follow-Up.
Clin Ophthalmol
October 2024
Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
Article Synopsis
- A study was conducted to compare the loss of corneal endothelial cells in glaucoma patients who underwent trabeculectomy (Trab) versus Ex-Press surgery (EXP).
- The research involved analyzing patient data over a three-year period, measuring corneal endothelial cell density (CED) before and after surgery using specialized microscopy.
- Results showed that EXP surgery led to significantly less cell loss compared to Trab, suggesting that EXP is a safer option in terms of preserving corneal health.
Modified ex-PRESS technique versus Ahmed glaucoma valve as primary glaucoma surgery for hereditary transthyretin amyloidosis glaucoma.
Amyloid
December 2024
Department of Ophthalmology, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
Background: To compare the efficacy of modified Ex-PRESS technique (ExP) versus Ahmed Glaucoma Valve (AGV) as primary surgery in hereditary transthyretin amyloidosis (ATTRv) secondary glaucoma.
Methods: Retrospective study at the national amyloidosis centre. Success was defined as an IOP ≥ 6 mmHg and ≤ 21 mmHg with no need for further glaucoma surgery or laser trabeculoplasty and without loss of light perception at the time of the last follow-up.
Glaucoma Ex-PRESS Implantation Surgery: Is There a Difference in Efficacy and Safety between Inpatient and Outpatient Management?
JMA J
July 2024
Department of Ophthalmology, Graduate of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Xen gel stent implant for persistent glaucoma after silicone oil removal.
Eur J Ophthalmol
August 2024
Eye Clinic, Department of Medical Science, Neuroscience and Sense Organs, University of Bari, 70124, Bari, Italy.
Purpose: To evaluate the effectiveness and safety of the XEN-Stent for managing unresponsive to medical therapy secondary glaucoma after silicone oil (SO) removal.
Methods: This retrospective chart reviewed 12 patients who underwent vitrectomy and SO endotamponade. They experienced intraocular pressure (IOP) elevation after SO removal despite taking the maximum tolerated glaucoma medication.
Comparison of corneal endothelial cell density reduction between primary open-angle glaucoma and pseudo-exfoliation glaucoma patients at 3 years after Ex-Press® surgery.
Int Ophthalmol
July 2024
Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama City, 930-0194, Japan.
Article Synopsis
- The study aimed to compare corneal endothelial cell (CED) loss after Ex-Press surgery in patients with primary open-angle glaucoma (POAG) versus pseudo-exfoliation glaucoma (PEX).
- A total of 119 eyes were analyzed over more than three years to measure CED before and after surgery using noncontact specular microscopy.
- Results showed that PEX patients experienced a more significant decline in CED compared to POAG patients, with a lower CED survival ratio in the PEX group after three years.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!